IRIS
SIMONE, Isabella Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.763
AS - Asia 5.393
EU - Europa 3.351
SA - Sud America 1.373
AF - Africa 245
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 9
Totale 24.147
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.594
SG - Singapore 2.059
CN - Cina 1.149
BR - Brasile 1.093
HK - Hong Kong 1.081
SE - Svezia 534
IT - Italia 519
DE - Germania 428
RU - Federazione Russa 400
UA - Ucraina 345
FI - Finlandia 329
FR - Francia 319
VN - Vietnam 306
GB - Regno Unito 213
IN - India 165
BD - Bangladesh 126
AR - Argentina 90
CA - Canada 87
IQ - Iraq 83
CI - Costa d'Avorio 69
ID - Indonesia 64
ZA - Sudafrica 53
TR - Turchia 50
EC - Ecuador 42
BE - Belgio 39
PK - Pakistan 39
MX - Messico 36
CO - Colombia 34
IE - Irlanda 32
JP - Giappone 32
PL - Polonia 32
MA - Marocco 31
UZ - Uzbekistan 31
VE - Venezuela 31
ES - Italia 28
PH - Filippine 27
NL - Olanda 25
SA - Arabia Saudita 25
AT - Austria 24
AE - Emirati Arabi Uniti 22
CL - Cile 21
UY - Uruguay 21
JO - Giordania 19
MY - Malesia 17
LT - Lituania 16
PY - Paraguay 15
TN - Tunisia 15
BO - Bolivia 14
KE - Kenya 14
OM - Oman 13
ET - Etiopia 12
CR - Costa Rica 11
PE - Perù 10
AZ - Azerbaigian 9
EG - Egitto 8
JM - Giamaica 8
NG - Nigeria 8
AU - Australia 7
BG - Bulgaria 7
EU - Europa 7
KZ - Kazakistan 7
NP - Nepal 7
RO - Romania 7
RS - Serbia 7
AO - Angola 6
BY - Bielorussia 6
DZ - Algeria 6
GE - Georgia 6
IL - Israele 6
IR - Iran 6
KW - Kuwait 6
NI - Nicaragua 6
PT - Portogallo 6
TW - Taiwan 6
CW - ???statistics.table.value.countryCode.CW??? 5
LB - Libano 5
SN - Senegal 5
AL - Albania 4
BH - Bahrain 4
DO - Repubblica Dominicana 4
GA - Gabon 4
GR - Grecia 4
KG - Kirghizistan 4
KR - Corea 4
LV - Lettonia 4
TH - Thailandia 4
CH - Svizzera 3
CZ - Repubblica Ceca 3
EE - Estonia 3
PA - Panama 3
PS - Palestinian Territory 3
TT - Trinidad e Tobago 3
BB - Barbados 2
BF - Burkina Faso 2
CY - Cipro 2
HN - Honduras 2
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
MK - Macedonia 2
Totale 24.111
Salva come PNG Salva come JPEG
Città #
Fairfield 1.523
Ashburn 1.333
Woodbridge 1.170
Singapore 1.090
Chandler 901
Houston 811
Jacksonville 785
Seattle 641
San Jose 620
Hong Kong 608
Wilmington 558
Cambridge 529
Ann Arbor 487
Nyköping 369
Beijing 279
New York 259
Roxbury 224
Lawrence 223
Lauterbourg 207
Dallas 182
Nanjing 180
Los Angeles 178
Boardman 154
Des Moines 150
Helsinki 124
Ho Chi Minh City 103
Bari 97
Princeton 94
Santa Clara 84
San Diego 75
São Paulo 73
Council Bluffs 71
Abidjan 69
Brooklyn 68
Nanchang 63
Munich 61
Inglewood 60
Hanoi 56
Hebei 55
London 52
Dearborn 51
Orem 51
Jiaxing 50
Buffalo 48
Shenyang 48
Rio de Janeiro 44
Denver 42
San Francisco 42
Frankfurt am Main 41
Tianjin 39
Falls Church 38
Brussels 37
Dong Ket 36
Belo Horizonte 35
Paris 35
Dublin 32
Atlanta 31
Marseille 31
Chicago 30
Tokyo 30
Baghdad 29
Jakarta 29
Changsha 28
Norwalk 28
Moscow 26
Tashkent 26
Warsaw 25
Redwood City 24
Guangzhou 23
Milan 23
Nuremberg 23
Pune 23
Phoenix 22
Boston 21
Johannesburg 21
Montreal 21
Columbus 20
Shanghai 20
Brasília 19
Curitiba 19
Rome 19
The Dalles 19
Falkenstein 18
Turin 18
Quito 17
Chennai 16
Stockholm 16
Toronto 16
Washington 16
Amman 15
Guayaquil 15
Istanbul 15
Lahore 15
Taranto 15
Campinas 14
Haiphong 14
Amsterdam 13
Addis Ababa 12
Dhaka 12
Jinan 12
Totale 16.234
Salva come PNG Salva come JPEG
Nome #
Adherence to riluzole in patients with amyotrophic lateral sclerosis: An observational study 667
Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study.J Neurol Sci. 2001 Jan 1;182(2):143-50 665
Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis 236
Corrigendum: Dysregulation of MicroRNAs and Target Genes Networks in Peripheral Blood of Patients With Sporadic Amyotrophic Lateral Sclerosis 232
Dysregulation of MicroRNAs and Target Genes Networks in Peripheral Blood of Patients With Sporadic Amyotrophic Lateral Sclerosis 190
Episodic memory and learning rates in amyotrophic lateral sclerosis without dementia 186
A rare association between multiple sclerosis and Charcot-Marie-Tooth type 1B 185
Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational study 180
Assisting persons with advanced amyotrophic lateral sclerosis in their leisure engagement and communication needs with a basic technology-aided program 180
Convexal subarachnoid hemorrhage and acute ischemic stroke: a border zone matter? 179
Time to generalization and prediction of survival in patients with amyotrophic lateral sclerosis: A retrospective observational study 177
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis 167
Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis 166
Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis 165
Pseudobulbar affect as a negative prognostic indicator in amyotrophic lateral sclerosis 161
Nutritional prognostic factors for survival in amyotrophic lateral sclerosis patients undergone percutaneous endoscopic gastrostomy placement 155
Multiparametric unconventional MRI study in early stage of ALS disease 154
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion 149
IMMUNOPATOLOGIA DELLA SCLEROSI MULTIPLA 144
A Novel CSF1R Mutation in a Patient with Clinical and Neuroradiological Features of Hereditary Diffuse Leukoencephalopathy with Axonal Spheroids 144
Cerebrospinal Fluid and Clinical Profiles in Adult Type 2–3 Spinal Muscular Atrophy Patients Treated with Nusinersen: An 18-Month Single-Centre Experience 144
Double-Blind Placebo-Controlled Trial on the Use of Acetyl-L-Carnitine for the Treatment of Amyotrophic Lateral Sclerosis (P04.151) 143
Analisi longitudinale dei livelli sierici di ICAM-1 solubile e dei subsets di linfociti T in pazienti con Sclerosi Multipla a decorso remittente in trattamento con IFNb-1b 143
The importance of maintaining the same order of performance of lung function and SNIP tests in patients with amyotrophic lateral sclerosis 137
CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients 136
Hirayama disease: the importance of an early diagnosis 136
Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis. 136
ALS multidisciplinary clinic and survival. Results from a population-based study in Southern Italy 135
The role of imaging in Hirayama disease 134
MR evaluation of encephalic leukoaraiosis in sudden sensorineural hearing loss (SSNHL) patients 133
Intrathecal immune response in human immunodeficiency virus infection 132
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry 130
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 126
Protein misfolding, amyotrophic lateral sclerosis and guanabenz: protocol for a phase II RCT with futility design (ProMISe trial) 126
1H-MR Spectroscopy profiles in normal appearing white matter(NAWM) of clinically isolated sindromes suggestive of multiple sclerosis(CIS) 125
Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study. 125
Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study 124
Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study 121
Long term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: the Italian experience 120
HFE p.H63D polymorphism does not influence ALS phenotype and survival 119
Motor-evoked potentials in amyotrophic lateral sclerosis: potential implications in detecting subclinical UMN involvement in lower motor neuron phenotype 119
Brain Cortex Thinning in Motor And Extra-motor Areas in Amyotrophyc Lateral Sclerosis 118
1H-MRSA comparison of normal appearing white matter in different clinical MS subgroups 118
Verbal Learning Abilities in ALS Patients (P01.109) 118
Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled,multicentre clinical trial for colchicine in ALS (Co-ALS) 118
Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSG. 117
Brain cortex thinning in motor and extra-motor areas in amyotrophic lateral sclerosis 116
Analysis of shared common genetic risk between amyotrophic lateral sclerosis and epilepsy 116
TBK1 is associated with ALS and ALS-FTD in Sardinian patients 113
Elevated plasma homocystein levels in patients with Amyotrophic lteral sclerosis 112
Trauma and amyotrophic lateral sclerosis: a case-control study from a population-based registry. 111
A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD 111
Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients 110
N-Acetyl-Aspartate (NAA) and Neurofilament-Light Chain (NF-L) in biological fluids as markers of neurodegeneration in ALS 109
High resolution proton MR-spectroscopy of cerebrospinal fluid in MS patients. Comparison with biochemical changes in demyelinating plaques 109
Is cerebrospinal fluid amyloid-β42 a promising biomarker of response to nusinersen in adult spinal muscular atrophy patients? 109
Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS 109
Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues 105
G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial) 105
99mTc-HM-PAO SPET and proton magnetic resonance spectroscopy in patients with ischaemic cerebral infarction 103
Alzheimer disease: comparison of 99mTc-HMPAO SPET and 1H-MRS data 103
Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances 103
Age-related gadolinium-enhancement of MRI brain lesions in multiple sclerosis. 103
BRAIN CORTEX THINNING IN MOTOR AND EXTRA-MOTOR AREAS IN AMYOTROPHIC LATERAL SCLEROSIS 102
Prognostic factors in ALS: A critical review 102
null 101
99Tcm-HMPAO SPET and 1H-MRS (Proton Magnetic Resonance Spectroscopy) in patients with ischaemic cerebral infarction 101
null 100
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis. 99
Incidence of amyotrophic lateral sclerosis in Europe 98
A novel KIF5A mutation in an Italian family marked by spastic paraparesis and congenital deafness 98
Cerebrospinal Fluid and Serum Neurofilament Light Chain Levels in ALS Patients 97
dentification of a point mutation impairing the binding between Aquaporin-4 and the Neuromyelitis Optica autoantibodies 97
Relationships between regional cortical atrophy and cognitive dysfunction in non-demented ALS patients 96
Intra blood-barrier (BBB) immune rersponse in HIV-infected patients 96
null 95
Life-threatening ADEM in an immunocompetent pregnant woman with concomitant asymptomatic Cytomegalovirus infection 95
Inclusion of motor evoked abnormalities in amyotrophic lateral sclerosis: a diagnostic algorithm to early classify lower motor neuron phenotypes 95
A 71-nucleotide deletion in the periaxin gene in an Italian patient with late-onset slowly progressive demyelinating CMT 94
Benign and malignant MS:clinical and 1H-MRS parameters associated with different MS courses 93
Adult-onset Rasmussen's encephalitis: anatomical-electrographic-clinical features of 7 Italian cases 93
A case of Landau-Kleffner syndrome secondary to inflammatory demyelinating disease 92
Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy 90
The contribution of (1)H-magnetic resonance spectroscopy in defining the pathophysiology of multiple sclerosis. 89
. Amyotrophic lateral sclerosis: a new missense mutation in the SOD1 gene 89
Whole-brain and regional brain atrophy in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol. 2007 Feb;28(2):255-9 88
Pseudobulbar affect (PBA) in an incident ALS cohort: results from the Apulia registry (SLAP). 88
null 88
Is Frontal Assessment Battery a useful instrument to detect cognitive impairment in ALS?. 88
Isoelectric focusing and crossed immunoelectrofocusing of cerebrospinal fluid proteins in neurological disorders 88
Brain cortical thinning in Motor and Extra-motor areas in Amyotrophic Lateral Sclerosis 86
null 85
Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3. 85
null 84
Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study 84
Acute changes in blood-CSF barrier permselectivity to serum proteins after intrathecal methotrexate and CNS irradiation 84
Patterns of multiple sclerosis (MS) plaques by magnetic resonance imaging (MRI) and proton-MR spectroscopy (1H-MRS) evaluation 83
null 83
N-Acetyl-Aspartate (NAA) and Neurofilament Light-Chain (NF-L) in Biological Fluids as Markers of Neurodegeneration in ALS 82
Sintesi intratecale di IgG in corso di infezioni da HIV 82
Totale 13.052
Salva come PNG Salva come JPEG
Categoria #
all - tutte 96.680
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.680
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021348 0 0 0 0 0 0 0 0 0 0 190 158
2021/20221.878 55 78 16 37 82 172 46 72 99 110 262 849
2022/20232.261 365 220 157 211 293 255 32 249 393 14 40 32
2023/2024809 57 153 51 39 54 232 21 34 18 21 5 124
2024/20253.356 107 65 322 119 88 285 207 274 173 194 491 1.031
2025/20267.062 1.070 279 410 718 660 431 943 245 660 724 922 0
Totale 24.945